FARMAPLUS
AMBLICOL 15 VIALS OF 10 ML
AMBLICOL 15 VIALS OF 10 ML
Secure payment
Discreet and sanitized package
Fast and safe shipping
Description
Description
Amblycol
Food supplement based on choline bitartrate, blueberry dry extract and vitamins.
Vitamins B6, B12 and C contribute to the normal functioning of the nervous system.
Flavor: strawberry.
Ingredients
Choline bitartrate, vitamin B6, vitamin B12, Bilberry; sweetener: stevia rebaudiana B.
Nutritional characteristics
| Medium tenors | daily dose |
| Choline bitartrate of which base hill |
500 mg 205 mg |
How to use
It is recommended to take one vial per day.
Shake vigorously before taking.
Warnings
Do not exceed the recommended daily dose.
Keep out of reach of children under 3 years.
Food supplements should not be used as a substitute for a varied diet and a healthy lifestyle.
Conservation
Store below 25°C.
Shelf life in intact packaging: 24 months.
Format
15 single-dose vials of oral solution, each containing 10 ml.
FARMAPLUS
AMBLICOL 15 VIALS OF 10 ML
AMBLICOL 15 VIALS OF 10 ML
Couldn't load pickup availability
Product images are purely indicative and may not be fully representative of the packaging and product features, as they may vary in color, size, or content. Any decorations, gift wrapping, and items included in the images for product presentation purposes will not be shipped with orders. Product names, ingredients, and percentages indicated in the descriptions are purely indicative and may be subject to change or updates by the manufacturers. Due to the impossibility of updating these updates in real time, the photos and technical information of the products listed on farmaInnovation.it may differ from those shown on the label or otherwise disclosed by the manufacturers. The only identifying element is the MINSAN (Ministry of Health) code. Farmacia Barni, farmainnovation.it , does not guarantee the accuracy and timeliness of the information published and declines all responsibility for any errors, omissions, or failure to update it. farmainnovation.it assumes no responsibility for damages of any kind that may arise from accessing the published information.
